Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
25
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Bitetti Teresa Marie | Director | 2 | $0 | $0 | 2024-06-04 |
| Bobilev Dmitri | Chief Medical Officer | 6 | $0 | $0 | 2024-06-04 |
| Rawat Mohit | President and CBO | 12 | $0 | $0 | 2024-06-04 |
| Bender Jeremy | Director | 2 | $0 | $0 | 2024-06-04 |
| Lee Philina | Director | 8 | $0 | $0 | 2024-06-04 |
| Burak Eric | Chief? Scientific Officer | 25 | $0 | $0 | 2024-06-04 |
| Valliant John | Chief Executive Officer | 65 | $0 | $1.60M | 2024-06-04 |
| Bergstrom Donald A | Director | 8 | $0 | $0 | 2024-06-04 |
| GANNON STEVEN | Director | 16 | $186.9K | $0 | 2024-06-04 |
| Crowley John J | Chief Financial Officer | 20 | $110.5K | $0 | 2024-06-04 |
| Meek David D. | Director | 2 | $0 | $0 | 2024-06-04 |
| Leamon Christopher P | Chief Scientific Officer | 10 | $0 | $0 | 2024-06-04 |
| Duncan Barbara Gayle | Director | 8 | $0 | $0 | 2024-06-04 |
| CAGNONI PABLO J | Director | 9 | $0 | $0 | 2024-06-04 |
| Khuong Chau Quang | Director | 11 | $22.10M | $0 | 2023-06-14 |
| Preston Heather | Director | 5 | $150.0K | $0 | 2023-06-14 |
| O'Leary James J | Chief Medical Officer | 7 | $5.1K | $0 | 2022-02-01 |
| ADAMS STREET PARTNERS LLC | 10% Owner | 30 | $0 | $103.4K | 2020-12-24 |
| BONDERMAN DAVID | Other | 4 | $4.25M | $0 | 2020-06-30 |
| VARIAN MEDICAL SYSTEMS INC | 10% Owner | 4 | $0 | $0 | 2020-06-30 |
| JOHNSON & JOHNSON | 10% Owner | 6 | $12.32M | $0 | 2020-06-30 |
| HealthCap VII, L.P. | 10% Owner | 5 | $4.08M | $0 | 2020-06-30 |
| Christenson Johan | Director | 8 | $7.36M | $0 | 2020-06-30 |
| ORBIMED CAPITAL LLC | Director | 4 | $15.27M | $0 | 2020-06-30 |
| Lamb Damian | Director | 1 | $0 | $0 | 2020-06-25 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Bergstrom Donald A | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| Bergstrom Donald A | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| Bergstrom Donald A | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| Bergstrom Donald A | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 34,000 | — | $0 | 0 | SEC↗ |
| Leamon Christopher P | Chief Scientific Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 63,700 | — | $0 | 0 | SEC↗ |
| Leamon Christopher P | Chief Scientific Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 106,100 | — | $0 | 0 | SEC↗ |
| Leamon Christopher P | Chief Scientific Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 250,000 | — | $0 | 0 | SEC↗ |
| Leamon Christopher P | Chief Scientific Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 218,000 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 63,700 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 69,890 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 44,754 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 38,561 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 72,340 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 81,090 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 159,928 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 139,000 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 106,100 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 250,000 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 168,200 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 45,533 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 45,533 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 41,000 | — | $0 | 0 | SEC↗ |
| Duncan Barbara Gayle | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| Duncan Barbara Gayle | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| Duncan Barbara Gayle | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| Duncan Barbara Gayle | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 30,000 | — | $0 | 0 | SEC↗ |
| Bender Jeremy | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 34,000 | — | $0 | 0 | SEC↗ |
| Bobilev Dmitri | Chief Medical Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 91,000 | — | $0 | 0 | SEC↗ |
| Bobilev Dmitri | Chief Medical Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 151,700 | — | $0 | 0 | SEC↗ |
| Bobilev Dmitri | Chief Medical Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 550,000 | — | $0 | 0 | SEC↗ |
| Meek David D. | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 34,000 | — | $0 | 0 | SEC↗ |
| Crowley John J | Chief Financial Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 167,000 | — | $0 | 0 | SEC↗ |
| Crowley John J | Chief Financial Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 313,359 | — | $0 | 0 | SEC↗ |
| Crowley John J | Chief Financial Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 106,100 | — | $0 | 0 | SEC↗ |
| Crowley John J | Chief Financial Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 250,000 | — | $0 | 0 | SEC↗ |
| Crowley John J | Chief Financial Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 63,700 | — | $0 | 0 | SEC↗ |
| Crowley John J | Chief Financial Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 138,000 | — | $0 | 0 | SEC↗ |
| Crowley John J | Chief Financial Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 60,852 | — | $0 | 0 | SEC↗ |
| Crowley John J | Chief Financial Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 26,972 | — | $0 | 0 | SEC↗ |
| Crowley John J | Chief Financial Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 38,561 | — | $0 | 0 | SEC↗ |
| Rawat Mohit | President & CBO | D To issuer deriv | 2024-06-04 | 2024-06-04 | 77,900 | — | $0 | 0 | SEC↗ |
| Rawat Mohit | President & CBO | D To issuer deriv | 2024-06-04 | 2024-06-04 | 300,000 | — | $0 | 0 | SEC↗ |
| Rawat Mohit | President & CBO | D To issuer deriv | 2024-06-04 | 2024-06-04 | 257,000 | — | $0 | 0 | SEC↗ |
| Rawat Mohit | President & CBO | D To issuer deriv | 2024-06-04 | 2024-06-04 | 135,500 | — | $0 | 0 | SEC↗ |
| Rawat Mohit | President & CBO | D To issuer deriv | 2024-06-04 | 2024-06-04 | 81,300 | — | $0 | 0 | SEC↗ |
| Lee Philina | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| Lee Philina | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| Lee Philina | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| Lee Philina | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 30,000 | — | $0 | 0 | SEC↗ |
| CAGNONI PABLO J | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 141,011 | — | $0 | 0 | SEC↗ |
| CAGNONI PABLO J | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 30,000 | — | $0 | 0 | SEC↗ |
| CAGNONI PABLO J | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| CAGNONI PABLO J | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| CAGNONI PABLO J | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| Valliant John | Chief Executive Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 533,095 | — | $0 | 0 | SEC↗ |
| Valliant John | Chief Executive Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 270,300 | — | $0 | 0 | SEC↗ |
| Valliant John | Chief Executive Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 606,721 | — | $0 | 0 | SEC↗ |
| Valliant John | Chief Executive Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 173,528 | — | $0 | 0 | SEC↗ |
| Valliant John | Chief Executive Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 206,541 | — | $0 | 0 | SEC↗ |
| Valliant John | Chief Executive Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 372,948 | — | $0 | 0 | SEC↗ |
| Valliant John | Chief Executive Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 336,000 | — | $0 | 0 | SEC↗ |
| Valliant John | Chief Executive Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 406,600 | — | $0 | 0 | SEC↗ |
| Valliant John | Chief Executive Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 500,000 | — | $0 | 0 | SEC↗ |
| Valliant John | Chief Executive Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 192,200 | — | $0 | 0 | SEC↗ |
| Valliant John | Chief Executive Officer | D To issuer deriv | 2024-06-04 | 2024-06-04 | 320,400 | — | $0 | 0 | SEC↗ |
| GANNON STEVEN | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 141,011 | — | $0 | 0 | SEC↗ |
| GANNON STEVEN | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 30,000 | — | $0 | 0 | SEC↗ |
| GANNON STEVEN | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| GANNON STEVEN | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| GANNON STEVEN | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| Bitetti Teresa Marie | Director | D To issuer deriv | 2024-06-04 | 2024-06-04 | 34,000 | — | $0 | 0 | SEC↗ |
| Leamon Christopher P | Chief Scientific Officer | D To issuer | 2024-06-04 | 2024-06-04 | 11,957 | — | $0 | 0 | SEC↗ |
| Burak Eric | Chief Technology Officer | D To issuer | 2024-06-04 | 2024-06-04 | 38,490 | — | $0 | 0 | SEC↗ |
| Crowley John J | Chief Financial Officer | D To issuer | 2024-06-04 | 2024-06-04 | 10,410 | — | $0 | 0 | SEC↗ |
| Rawat Mohit | President & CBO | D To issuer | 2024-06-04 | 2024-06-04 | 21,699 | — | $0 | 0 | SEC↗ |
| Valliant John | Chief Executive Officer | D To issuer | 2024-06-04 | 2024-06-04 | 318,147 | — | $0 | 0 | SEC↗ |
| GANNON STEVEN | Director | D To issuer | 2024-06-04 | 2024-06-04 | 56,400 | — | $0 | 0 | SEC↗ |
| Valliant John | Chief Executive Officer | A Award deriv | 2024-01-04 | 2024-01-05 | 192,200 | — | $0 | 192,200 | SEC↗ |
| Valliant John | Chief Executive Officer | A Award deriv | 2024-01-04 | 2024-01-05 | 320,400 | — | $0 | 320,400 | SEC↗ |
| Bobilev Dmitri | Chief Medical Officer | A Award deriv | 2024-01-04 | 2024-01-05 | 91,000 | — | $0 | 91,000 | SEC↗ |
| Bobilev Dmitri | Chief Medical Officer | A Award deriv | 2024-01-04 | 2024-01-05 | 151,700 | — | $0 | 151,700 | SEC↗ |
| Rawat Mohit | President & CBO | A Award deriv | 2024-01-04 | 2024-01-05 | 81,300 | — | $0 | 81,300 | SEC↗ |
| Rawat Mohit | President & CBO | A Award deriv | 2024-01-04 | 2024-01-05 | 135,500 | — | $0 | 135,500 | SEC↗ |
| Burak Eric | Chief Technology Officer | A Award deriv | 2024-01-04 | 2024-01-05 | 106,100 | — | $0 | 106,100 | SEC↗ |
| Burak Eric | Chief Technology Officer | A Award deriv | 2024-01-04 | 2024-01-05 | 63,700 | — | $0 | 63,700 | SEC↗ |
| Crowley John J | Chief Financial Officer | A Award deriv | 2024-01-04 | 2024-01-05 | 63,700 | — | $0 | 63,700 | SEC↗ |
| Crowley John J | Chief Financial Officer | A Award deriv | 2024-01-04 | 2024-01-05 | 106,100 | — | $0 | 106,100 | SEC↗ |
| Leamon Christopher P | Chief Scientific Officer | A Award deriv | 2024-01-04 | 2024-01-05 | 106,100 | — | $0 | 106,100 | SEC↗ |
| Leamon Christopher P | Chief Scientific Officer | A Award deriv | 2024-01-04 | 2024-01-05 | 63,700 | — | $0 | 63,700 | SEC↗ |
| Bender Jeremy | Director | A Award deriv | 2023-10-16 | 2023-10-16 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Bitetti Teresa Marie | Director | A Award deriv | 2023-10-16 | 2023-10-16 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Meek David D. | Director | A Award deriv | 2023-10-16 | 2023-10-16 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Rawat Mohit | President & CBO | A Award | 2023-08-31 | 2024-01-05 | 12,843 | — | $0 | 12,843 | SEC↗ |
| Leamon Christopher P | Chief Scientific Officer | A Award | 2023-08-31 | 2024-01-05 | 11,957 | — | $0 | 11,957 | SEC↗ |
| Bergstrom Donald A | Director | A Award deriv | 2023-06-14 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| CAGNONI PABLO J | Director | A Award deriv | 2023-06-14 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Duncan Barbara Gayle | Director | A Award deriv | 2023-06-14 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| GANNON STEVEN | Director | A Award deriv | 2023-06-14 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Khuong Chau Quang | Director | A Award deriv | 2023-06-14 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Lee Philina | Director | A Award deriv | 2023-06-14 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Preston Heather | Director | A Award deriv | 2023-06-14 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Burak Eric | Chief Technology Officer | A Award deriv | 2023-01-05 | 2023-01-09 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Crowley John J | Chief Financial Officer | A Award deriv | 2023-01-05 | 2023-01-09 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Leamon Christopher P | Chief Scientific Officer | A Award deriv | 2023-01-05 | 2023-01-09 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Rawat Mohit | President and CBO | A Award deriv | 2023-01-05 | 2023-01-09 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Valliant John | Chief Executive Officer | A Award deriv | 2023-01-05 | 2023-01-09 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Khuong Chau Quang | Director | A Award | 2022-11-11 | 2022-11-14 | 42,093 | $2.38 | $100.2K | 42,093 | SEC↗ |
| Bobilev Dmitri | Chief Medical Officer | A Award deriv | 2022-11-07 | 2022-11-07 | 550,000 | — | $0 | 550,000 | SEC↗ |
| GANNON STEVEN | Director | P Buy | 2022-08-11 | 2022-08-11 | 44,400 | $2.03 | $90.1K | 56,400 | SEC↗ |
| Bergstrom Donald A | Director | A Award deriv | 2022-06-14 | 2022-06-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| CAGNONI PABLO J | Director | A Award deriv | 2022-06-14 | 2022-06-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Duncan Barbara Gayle | Director | A Award deriv | 2022-06-14 | 2022-06-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| GANNON STEVEN | Director | A Award deriv | 2022-06-14 | 2022-06-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Khuong Chau Quang | Director | A Award deriv | 2022-06-14 | 2022-06-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Lee Philina | Director | A Award deriv | 2022-06-14 | 2022-06-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Preston Heather | Director | A Award deriv | 2022-06-14 | 2022-06-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-27 | 2022-04-27 | 4,511 | $6.03 | $27.2K | 318,147 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-26 | 2022-04-27 | 2,147 | $6.07 | $13.0K | 322,658 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-25 | 2022-04-27 | 2,036 | $6.03 | $12.3K | 324,805 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-21 | 2022-04-22 | 922 | $6.01 | $5.5K | 326,841 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-20 | 2022-04-22 | 367 | $6.02 | $2.2K | 327,763 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-13 | 2022-04-13 | 11,994 | $6.41 | $76.9K | 328,130 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-12 | 2022-04-13 | 18,255 | $7.10 | $129.6K | 340,124 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-11 | 2022-04-13 | 2,600 | $7.37 | $19.2K | 358,379 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-08 | 2022-04-08 | 826 | $7.52 | $6.2K | 360,979 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-07 | 2022-04-08 | 1,255 | $7.56 | $9.5K | 361,805 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-06 | 2022-04-08 | 100 | $7.58 | $758 | 363,060 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-05 | 2022-04-05 | 2,100 | $7.67 | $16.1K | 363,160 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-04 | 2022-04-05 | 700 | $7.81 | $5.5K | 365,260 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-04-01 | 2022-04-05 | 1,000 | $7.75 | $7.8K | 365,960 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-30 | 2022-04-01 | 300 | $7.52 | $2.3K | 366,960 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-29 | 2022-03-29 | 200 | $7.52 | $1.5K | 367,260 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-28 | 2022-03-29 | 9,600 | $7.55 | $72.5K | 367,460 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-25 | 2022-03-29 | 500 | $7.42 | $3.7K | 377,060 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-23 | 2022-03-24 | 100 | $7.50 | $750 | 378,260 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-22 | 2022-03-24 | 4,000 | $7.53 | $30.1K | 378,360 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-21 | 2022-03-21 | 1,500 | $7.47 | $11.2K | 382,360 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-21 | 2022-03-24 | 700 | $7.46 | $5.2K | 377,560 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-18 | 2022-03-21 | 1,204 | $7.61 | $9.2K | 383,860 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-17 | 2022-03-21 | 900 | $7.51 | $6.8K | 385,064 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-16 | 2022-03-16 | 100 | $6.99 | $699 | 385,964 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-15 | 2022-03-16 | 100 | $7.12 | $712 | 386,064 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-14 | 2022-03-16 | 1,300 | $6.96 | $9.0K | 386,164 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-11 | 2022-03-14 | 100 | $7.13 | $713 | 387,464 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-10 | 2022-03-14 | 1,900 | $7.06 | $13.4K | 387,564 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-09 | 2022-03-14 | 822 | $6.94 | $5.7K | 389,464 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-08 | 2022-03-08 | 3,004 | $6.92 | $20.8K | 390,286 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-07 | 2022-03-08 | 3,100 | $6.99 | $21.7K | 393,290 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-04 | 2022-03-08 | 8,400 | $7.32 | $61.5K | 396,390 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-03 | 2022-03-03 | 200 | $7.28 | $1.5K | 404,790 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-02 | 2022-03-03 | 26,546 | $7.44 | $197.5K | 404,990 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-03-01 | 2022-03-03 | 847 | $7.37 | $6.2K | 431,536 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-02-28 | 2022-02-28 | 3,100 | $7.40 | $22.9K | 432,383 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-02-25 | 2022-02-28 | 8,152 | $7.57 | $61.7K | 435,483 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-02-24 | 2022-02-28 | 2,500 | $7.41 | $18.5K | 443,635 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-02-23 | 2022-02-23 | 29,299 | $7.77 | $227.7K | 446,135 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-02-22 | 2022-02-23 | 4,100 | $7.85 | $32.2K | 475,434 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-02-18 | 2022-02-23 | 4,898 | $7.88 | $38.6K | 479,534 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-02-17 | 2022-02-17 | 1,700 | $7.98 | $13.6K | 484,432 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-02-16 | 2022-02-17 | 33,202 | $7.99 | $265.3K | 486,132 | SEC↗ |
| Valliant John | Chief Executive Officer | S Sale | 2022-02-15 | 2022-02-17 | 12,600 | $8.33 | $105.0K | 519,334 | SEC↗ |
| Burak Eric | Chief? Scientific Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 168,200 | — | $0 | 168,200 | SEC↗ |
| Crowley John J | Chief Financial Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 167,000 | — | $0 | 167,000 | SEC↗ |
| O'Leary James J | Chief Medical Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 159,000 | — | $0 | 159,000 | SEC↗ |
| Rawat Mohit | President and CBO | A Award deriv | 2022-02-01 | 2022-02-03 | 77,900 | — | $0 | 77,900 | SEC↗ |
| Valliant John | Chief Executive Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 406,600 | — | $0 | 406,600 | SEC↗ |
| Leamon Christopher P | Chief Scientific Officer | A Award deriv | 2021-11-01 | 2021-11-02 | 218,000 | — | $0 | 218,000 | SEC↗ |
| Rawat Mohit | President and CBO | A Award deriv | 2021-09-27 | 2021-09-30 | 257,000 | — | $0 | 257,000 | SEC↗ |
| Crowley John J | Chief Financial Officer | A Award | 2021-08-31 | 2022-02-03 | 3,910 | — | $0 | 10,410 | SEC↗ |
| O'Leary James J | Chief Medical Officer | A Award | 2021-08-31 | 2022-02-03 | 1,722 | — | $0 | 2,022 | SEC↗ |
| GANNON STEVEN | Director | P Buy | 2021-08-23 | 2021-08-23 | 2,829 | $7.99 | $22.6K | 12,000 | SEC↗ |
| GANNON STEVEN | Director | P Buy | 2021-08-19 | 2021-08-20 | 3,000 | $8.05 | $24.2K | 9,171 | SEC↗ |
| GANNON STEVEN | Director | P Buy | 2021-08-18 | 2021-08-20 | 171 | $8.05 | $1.4K | 6,171 | SEC↗ |
| GANNON STEVEN | Director | P Buy | 2021-08-16 | 2021-08-17 | 6,000 | $8.10 | $48.6K | 6,000 | SEC↗ |
| Bergstrom Donald A | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| CAGNONI PABLO J | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Duncan Barbara Gayle | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| GANNON STEVEN | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Khuong Chau Quang | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Lee Philina | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Preston Heather | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Bergstrom Donald A | Director | A Award deriv | 2021-04-01 | 2021-04-01 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Lee Philina | Director | A Award deriv | 2021-02-11 | 2021-02-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| O'Leary James J | Chief Medical Officer | A Award deriv | 2021-02-04 | 2021-02-08 | 114,000 | — | $0 | 114,000 | SEC↗ |
| Burak Eric | Chief Scientific Officer | A Award deriv | 2021-02-04 | 2021-02-08 | 136,600 | — | $0 | 136,600 | SEC↗ |
| Burak Eric | Chief Scientific Officer | A Award deriv | 2021-02-04 | 2021-02-08 | 139,000 | — | $0 | 139,000 | SEC↗ |
| Burak Eric | Chief Scientific Officer | A Award deriv | 2021-02-04 | 2021-02-08 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Valliant John | Chief Executive Officer | A Award deriv | 2021-02-04 | 2021-02-08 | 336,000 | — | $0 | 336,000 | SEC↗ |
| Crowley John J | Chief Financial Officer | A Award deriv | 2021-02-04 | 2021-02-08 | 138,000 | — | $0 | 138,000 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | S Sale | 2020-12-24 | 2020-12-29 | 469 | $12.32 | $5.8K | 431,117 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | S Sale | 2020-12-24 | 2020-12-29 | 455 | $12.32 | $5.6K | 418,190 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | S Sale | 2020-12-24 | 2020-12-29 | 681 | $12.32 | $8.4K | 626,000 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | S Sale | 2020-12-24 | 2020-12-29 | 611 | $12.32 | $7.5K | 561,634 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | S Sale | 2020-12-24 | 2020-12-29 | 1,584 | $12.32 | $19.5K | 1,457,115 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | S Sale | 2020-12-23 | 2020-12-28 | 547 | $12.39 | $6.8K | 418,645 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | S Sale | 2020-12-23 | 2020-12-28 | 734 | $12.39 | $9.1K | 562,245 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | S Sale | 2020-12-23 | 2020-12-28 | 564 | $12.39 | $7.0K | 431,586 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | S Sale | 2020-12-23 | 2020-12-28 | 1,905 | $12.39 | $23.6K | 1,458,699 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | S Sale | 2020-12-23 | 2020-12-28 | 819 | $12.39 | $10.1K | 626,681 | SEC↗ |
| Duncan Barbara Gayle | Director | A Award deriv | 2020-10-30 | 2020-11-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ORBIMED CAPITAL LLC | Director | C Conversion deriv | 2020-06-30 | 2020-07-02 | 11,878,051 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 2,143,200 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 2,237,832 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 961,412 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 642,260 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 1,595,823 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 862,558 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 5,560,341 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 2,388,822 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 1,645,147 | — | $0 | 0 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 662,111 | — | $0 | 0 | SEC↗ |
| VARIAN MEDICAL SYSTEMS INC | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 2,666,667 | — | $0 | 0 | SEC↗ |
| VARIAN MEDICAL SYSTEMS INC | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 14,517,619 | — | $0 | 0 | SEC↗ |
| Christenson Johan | Director | C Conversion deriv | 2020-06-30 | 2020-07-02 | 5,712,216 | — | $0 | 0 | SEC↗ |
| Christenson Johan | Director | C Conversion deriv | 2020-06-30 | 2020-07-02 | 13,333,333 | — | $0 | 0 | SEC↗ |
| HealthCap VII, L.P. | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 13,333,333 | — | $0 | 0 | SEC↗ |
| HealthCap VII, L.P. | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 5,712,216 | — | $0 | 0 | SEC↗ |
| Khuong Chau Quang | Director | C Conversion deriv | 2020-06-30 | 2020-07-02 | 11,878,051 | — | $0 | 0 | SEC↗ |
| BONDERMAN DAVID | Other | C Conversion deriv | 2020-06-30 | 2020-07-02 | 4,289,296 | — | $0 | 0 | SEC↗ |
| BONDERMAN DAVID | Other | C Conversion deriv | 2020-06-30 | 2020-07-02 | 8,000,000 | — | $0 | 0 | SEC↗ |
| JOHNSON & JOHNSON | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 10,666,667 | — | $0 | 0 | SEC↗ |
| JOHNSON & JOHNSON | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 5,059,460 | — | $0 | 0 | SEC↗ |
| JOHNSON & JOHNSON | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 89,118 | — | $0 | 89,118 | SEC↗ |
| JOHNSON & JOHNSON | 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 475,802 | — | $0 | 0 | SEC↗ |
| ORBIMED CAPITAL LLC | Director | P Buy | 2020-06-30 | 2020-07-02 | 192,100 | $17.00 | $3.27M | 192,100 | SEC↗ |
| ORBIMED CAPITAL LLC | Director | P Buy | 2020-06-30 | 2020-07-02 | 705,900 | $17.00 | $12.00M | 2,930,670 | SEC↗ |
| ORBIMED CAPITAL LLC | Director | C Conversion | 2020-06-30 | 2020-07-02 | 2,224,770 | — | $0 | 2,224,770 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 298,898 | — | $0 | 298,898 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 124,013 | — | $0 | 432,150 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 120,294 | — | $0 | 419,192 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 180,072 | — | $0 | 627,500 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 419,148 | — | $0 | 1,460,604 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 161,556 | — | $0 | 562,979 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 308,137 | — | $0 | 308,137 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 401,423 | — | $0 | 401,423 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 1,041,456 | — | $0 | 1,041,456 | SEC↗ |
| ADAMS STREET PARTNERS LLC | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 447,428 | — | $0 | 447,428 | SEC↗ |
| VARIAN MEDICAL SYSTEMS INC | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 499,468 | — | $0 | 499,468 | SEC↗ |
| VARIAN MEDICAL SYSTEMS INC | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 2,719,164 | — | $0 | 3,218,632 | SEC↗ |
| Christenson Johan | Director | C Conversion | 2020-06-30 | 2020-07-02 | 2,497,345 | — | $0 | 2,497,345 | SEC↗ |
| Christenson Johan | Director | C Conversion | 2020-06-30 | 2020-07-02 | 1,069,902 | — | $0 | 3,567,247 | SEC↗ |
| Christenson Johan | Director | P Buy | 2020-06-30 | 2020-07-02 | 240,000 | $17.00 | $4.08M | 3,807,247 | SEC↗ |
| HealthCap VII, L.P. | 10% Owner | P Buy | 2020-06-30 | 2020-07-02 | 240,000 | $17.00 | $4.08M | 3,807,247 | SEC↗ |
| HealthCap VII, L.P. | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 1,069,902 | — | $0 | 3,567,247 | SEC↗ |
| HealthCap VII, L.P. | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 2,497,345 | — | $0 | 2,497,345 | SEC↗ |
| Khuong Chau Quang | Director | C Conversion | 2020-06-30 | 2020-07-02 | 2,224,770 | — | $0 | 2,224,770 | SEC↗ |
| Khuong Chau Quang | Director | P Buy | 2020-06-30 | 2020-07-02 | 192,100 | $17.00 | $3.27M | 192,100 | SEC↗ |
| Khuong Chau Quang | Director | P Buy | 2020-06-30 | 2020-07-02 | 705,900 | $17.00 | $12.00M | 2,930,670 | SEC↗ |
| Crowley John J | Chief Financial Officer | P Buy | 2020-06-30 | 2020-07-02 | 6,500 | $17.00 | $110.5K | 6,500 | SEC↗ |
| Preston Heather | Director | P Buy | 2020-06-30 | 2020-07-02 | 8,823 | $17.00 | $150.0K | 8,823 | SEC↗ |
| O'Leary James J | Chief Medical Officer | P Buy | 2020-06-30 | 2020-07-02 | 300 | $17.00 | $5.1K | 300 | SEC↗ |
| BONDERMAN DAVID | Other | P Buy | 2020-06-30 | 2020-07-02 | 250,000 | $17.00 | $4.25M | 2,551,794 | SEC↗ |
| BONDERMAN DAVID | Other | C Conversion | 2020-06-30 | 2020-07-02 | 2,301,794 | — | $0 | 2,301,794 | SEC↗ |
| JOHNSON & JOHNSON | 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 2,945,516 | — | $0 | 2,945,516 | SEC↗ |
| JOHNSON & JOHNSON | 10% Owner | P Buy | 2020-06-30 | 2020-07-02 | 725,000 | $17.00 | $12.32M | 3,670,516 | SEC↗ |
| Burak Eric | Chief Scientific Officer | A Award deriv | 2020-06-25 | 2020-06-30 | 69,980 | — | $0 | 69,980 | SEC↗ |
| Burak Eric | Chief Scientific Officer | A Award deriv | 2020-06-25 | 2020-06-30 | 44,754 | — | $0 | 44,754 | SEC↗ |
| Preston Heather | Director | A Award deriv | 2020-06-25 | 2020-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CAGNONI PABLO J | Director | A Award deriv | 2020-06-25 | 2020-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Christenson Johan | Director | A Award deriv | 2020-06-25 | 2020-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Khuong Chau Quang | Director | A Award deriv | 2020-06-25 | 2020-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Valliant John | Chief Executive Officer | A Award deriv | 2020-06-25 | 2020-06-30 | 372,948 | — | $0 | 372,948 | SEC↗ |
| Valliant John | Chief Executive Officer | A Award deriv | 2020-06-25 | 2020-06-30 | 206,541 | — | $0 | 206,541 | SEC↗ |
| Lamb Damian | Director | A Award deriv | 2020-06-25 | 2020-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Crowley John J | Chief Financial Officer | A Award deriv | 2020-06-25 | 2020-06-30 | 60,852 | — | $0 | 60,852 | SEC↗ |
| Crowley John J | Chief Financial Officer | A Award deriv | 2020-06-25 | 2020-06-30 | 26,972 | — | $0 | 26,972 | SEC↗ |
| O'Leary James J | Chief Medical Officer | A Award deriv | 2020-06-25 | 2020-06-30 | 60,852 | — | $0 | 60,852 | SEC↗ |
| O'Leary James J | Chief Medical Officer | A Award deriv | 2020-06-25 | 2020-06-30 | 26,971 | — | $0 | 26,971 | SEC↗ |
| GANNON STEVEN | Director | A Award deriv | 2020-06-25 | 2020-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Christenson Johan | Director | P Buy deriv | 2020-06-02 | 2020-06-30 | 2,856,108 | $1.15 | $3.28M | 5,712,216 | SEC↗ |
| Khuong Chau Quang | Director | P Buy deriv | 2020-06-02 | 2020-06-30 | 5,939,025 | $1.15 | $6.83M | 11,878,051 | SEC↗ |
| O'Leary James J | Chief Medical Officer | A Award deriv | 2020-03-16 | 2020-06-30 | 351,921 | — | $0 | 351,921 | SEC↗ |
| Burak Eric | Chief Scientific Officer | A Award deriv | 2020-02-06 | 2020-06-30 | 38,561 | — | $0 | 38,561 | SEC↗ |
| Valliant John | Chief Executive Officer | A Award deriv | 2020-02-06 | 2020-06-30 | 173,528 | — | $0 | 173,528 | SEC↗ |
| Crowley John J | Chief Financial Officer | A Award deriv | 2020-02-06 | 2020-06-30 | 38,561 | — | $0 | 38,561 | SEC↗ |
| GANNON STEVEN | Director | A Award deriv | 2020-01-19 | 2020-06-30 | 141,011 | — | $0 | 141,011 | SEC↗ |
| Christenson Johan | Director | A Award deriv | 2020-01-10 | 2020-06-30 | 576,233 | — | $0 | 576,233 | SEC↗ |
| Khuong Chau Quang | Director | A Award deriv | 2020-01-10 | 2020-06-30 | 359,377 | — | $0 | 359,377 | SEC↗ |